Skip to main content

Proceeding contribution from Chris McCafferty (Labour) in the House of Commons on Tuesday, 17 July 2007. It occurred during Adjournment debate on Epilepsy Services.


Epilepsy Services

The hon. Lady makes some valid and crucial points, and I agree with her entirely. All her points are reflected strongly in the report. Many such young people find that they have no future—their lives are wasted simply because the initial diagnosis is incorrect, or they are not diagnosed correctly at all. The point about the economic cost—the cost to the health service, and the cost in benefit terms of wasted opportunities and wasted lives—is clear. As I said, 70 per cent. of the UK population with epilepsy could be seizure-free with optimal treatment. However, only 52 per cent. are, which means that 69,000 people in the UK who experience seizures could in fact be seizure-free. The human cost of those failings, as the hon. Lady has pointed out, is huge—for the individuals concerned, for their families, and indeed for society. Not only do they receive treatment for a condition that they do not have, but their true condition is not treated. The NICE guidelines on epilepsy recommend that individuals requiring an MRI scan should have the test performed soon. The guideline development group subsequently decided that ““soon”” meant being seen within four weeks. In a recent survey by Epilepsy Action, only 26 per cent. of the 185 respondents who had undergone an MRI scan within the past two years said that they had undergone it within four weeks. Surgery should also be made available for all people with epilepsy for whom it is indicated. There is a clear saving when we take into account the alternative of expensive lifetime medication and occasional hospitalisation —and, of course, a health benefit to the individual. Patients who are successfully treated also have better employment prospects. They are less dependent, and the high initial expenditure on epilepsy surgery would result in long-term cost savings. In recent years there has been an increase in reported epilepsy deaths, the majority of which have involved SUDEP—sudden unexpected death in epilepsy. SUDEP deaths are usually referred to coroners, as they require specialist investigation. I have a particular interest in the draft Coroners Bill, because Harold Shipman practised in my constituency. I have come to realise that the lack of standardisation and quality assurance in post-mortem investigations and certification of SUDEP deaths is a key barrier to the implementation of recognised prevention strategies.


Secondary information

Type
Proceeding contribution
Reference
463 c24-5WH 
Session
2006-07
Chamber / Committee
Westminster Hall
Subjects
Health services Diseases Epilepsy NHS
Link
View this Proceeding contribution on www.publications.parliament.uk